Related Experiment Video

Updated: Sep 27, 2026

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

A clinical pathway for pediatric gastroenteritis

Susan Jones1

  • 1University of Oklahoma, College of Nursing, USA.

Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|February 13, 2003
PubMed

Insights

Pediatric gastroenteritis is a common cause of hospitalization, costing billions annually. This review introduces a clinical pathway to improve care and provides resources for parents managing childhood gastroenteritis at home.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Pathway Development
  • Healthcare Management

Background:

  • Gastroenteritis is a leading cause of hospitalization for children under five in the U.S.
  • Annual healthcare costs for pediatric gastroenteritis exceed $2 billion.
  • Existing treatment guidelines require integration into a standardized care approach.

Purpose of the Study:

  • To review the causes and treatment guidelines for pediatric gastroenteritis.
  • To develop and discuss the implementation of a clinical pathway for hospitalized pediatric gastroenteritis patients.
  • To provide resources for home management of gastroenteritis in children.

Main Methods:

  • Review of the 1996 American Academy of Pediatrics Guidelines for gastroenteritis treatment.
  • Integration of guidelines with recent literature to create a clinical pathway.
  • Development of a parent teaching tool for home care.

Main Results:

  • A comprehensive clinical pathway for pediatric gastroenteritis management was developed.
  • The importance and implementation process of clinical pathways are discussed.
  • A parent-focused educational tool for home management was created.

Conclusions:

  • Clinical pathways can enhance the care of hospitalized pediatric patients with gastroenteritis.
  • Standardized care improves outcomes and resource utilization.
  • Accessible resources support effective home management and reduce readmissions.

More Related Videos

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through interaction...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...